Predictive oncology inc. announces new ceo

Minneapolis, march 23, 2021 (globe newswire) -- predictive oncology (nasdaq: poai), a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, is excited to announce today that they have appointed j. melville (“mel”) engle as chief executive officer of the company.
POAI Ratings Summary
POAI Quant Ranking